vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and MultiSensor AI Holdings, Inc. (MSAI). Click either name above to swap in a different company.

MultiSensor AI Holdings, Inc. is the larger business by last-quarter revenue ($1.4M vs $1.1M, roughly 1.2× Insight Molecular Diagnostics Inc.). MultiSensor AI Holdings, Inc. runs the higher net margin — -164.1% vs -2015.4%, a 1851.2% gap on every dollar of revenue. On growth, MultiSensor AI Holdings, Inc. posted the faster year-over-year revenue change (-0.9% vs -23.4%). MultiSensor AI Holdings, Inc. produced more free cash flow last quarter ($-2.6M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -21.9%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Figure AI, Inc. is an American robotics company developing AI-powered humanoid robots. The company was founded in 2022 by Brett Adcock, also known for founding Archer Aviation and Vettery.

IMDX vs MSAI — Head-to-Head

Bigger by revenue
MSAI
MSAI
1.2× larger
MSAI
$1.4M
$1.1M
IMDX
Growing faster (revenue YoY)
MSAI
MSAI
+22.5% gap
MSAI
-0.9%
-23.4%
IMDX
Higher net margin
MSAI
MSAI
1851.2% more per $
MSAI
-164.1%
-2015.4%
IMDX
More free cash flow
MSAI
MSAI
$4.4M more FCF
MSAI
$-2.6M
$-7.0M
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-21.9%
MSAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMDX
IMDX
MSAI
MSAI
Revenue
$1.1M
$1.4M
Net Profit
$-23.0M
$-2.3M
Gross Margin
42.5%
Operating Margin
-2057.5%
-171.6%
Net Margin
-2015.4%
-164.1%
Revenue YoY
-23.4%
-0.9%
Net Profit YoY
31.5%
23.7%
EPS (diluted)
$-0.75
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
MSAI
MSAI
Q4 25
$1.1M
$1.4M
Q3 25
$260.0K
$1.6M
Q2 25
$518.0K
$1.4M
Q1 25
$2.1M
$1.2M
Q4 24
$1.5M
$1.4M
Q3 24
$115.0K
$1.6M
Q2 24
$104.0K
$2.1M
Q1 24
$176.0K
$2.3M
Net Profit
IMDX
IMDX
MSAI
MSAI
Q4 25
$-23.0M
$-2.3M
Q3 25
$-10.9M
$-1.7M
Q2 25
$-9.7M
$-3.3M
Q1 25
$-6.7M
$-4.4M
Q4 24
$-33.5M
$-3.0M
Q3 24
$-13.5M
$-8.2M
Q2 24
$-4.5M
$-6.4M
Q1 24
$-9.1M
$-3.9M
Gross Margin
IMDX
IMDX
MSAI
MSAI
Q4 25
42.5%
Q3 25
53.5%
Q2 25
67.6%
Q1 25
62.0%
Q4 24
40.0%
Q3 24
43.5%
Q2 24
48.1%
Q1 24
25.6%
Operating Margin
IMDX
IMDX
MSAI
MSAI
Q4 25
-2057.5%
-171.6%
Q3 25
-4249.2%
-107.6%
Q2 25
-1900.0%
-233.8%
Q1 25
-318.0%
-394.6%
Q4 24
-2262.9%
-199.6%
Q3 24
-11752.2%
-541.5%
Q2 24
-4453.8%
-228.1%
Q1 24
-5265.3%
-112.7%
Net Margin
IMDX
IMDX
MSAI
MSAI
Q4 25
-2015.4%
-164.1%
Q3 25
-4174.6%
-106.5%
Q2 25
-1880.7%
-234.1%
Q1 25
-312.0%
-379.1%
Q4 24
-2255.1%
-213.2%
Q3 24
-11733.0%
-511.5%
Q2 24
-4355.8%
-300.8%
Q1 24
-5186.9%
-172.4%
EPS (diluted)
IMDX
IMDX
MSAI
MSAI
Q4 25
$-0.75
$-0.02
Q3 25
$-0.34
$-0.05
Q2 25
$-0.30
$-0.10
Q1 25
$-0.26
$-0.14
Q4 24
$-2.19
$0.07
Q3 24
$-0.98
$-0.34
Q2 24
$-0.36
$-0.47
Q1 24
$-1.13
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
MSAI
MSAI
Cash + ST InvestmentsLiquidity on hand
$11.6M
$24.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-31.5M
$32.0M
Total Assets
$25.8M
$35.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
MSAI
MSAI
Q4 25
$11.6M
$24.4M
Q3 25
$18.7M
$1.1M
Q2 25
$24.3M
$3.2M
Q1 25
$31.0M
$4.7M
Q4 24
$8.6M
$4.4M
Q3 24
$3.4M
$8.6M
Q2 24
$9.3M
$234.0K
Q1 24
$5.6M
$491.0K
Total Debt
IMDX
IMDX
MSAI
MSAI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$642.0K
Q1 24
$2.8M
Stockholders' Equity
IMDX
IMDX
MSAI
MSAI
Q4 25
$-31.5M
$32.0M
Q3 25
$-9.2M
$8.3M
Q2 25
$1.1M
$9.8M
Q1 25
$10.2M
$12.9M
Q4 24
$-12.3M
$12.3M
Q3 24
$9.7M
$15.6M
Q2 24
$22.7M
$1.6M
Q1 24
$11.6M
$1.4M
Total Assets
IMDX
IMDX
MSAI
MSAI
Q4 25
$25.8M
$35.5M
Q3 25
$43.9M
$11.9M
Q2 25
$50.5M
$14.6M
Q1 25
$60.4M
$16.4M
Q4 24
$35.1M
$15.5M
Q3 24
$70.2M
$18.9M
Q2 24
$74.7M
$16.4M
Q1 24
$71.0M
$14.1M
Debt / Equity
IMDX
IMDX
MSAI
MSAI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.41×
Q1 24
2.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
MSAI
MSAI
Operating Cash FlowLast quarter
$-5.5M
$-2.2M
Free Cash FlowOCF − Capex
$-7.0M
$-2.6M
FCF MarginFCF / Revenue
-616.7%
-187.3%
Capex IntensityCapex / Revenue
129.9%
26.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M
$-9.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
MSAI
MSAI
Q4 25
$-5.5M
$-2.2M
Q3 25
$-4.5M
$-1.8M
Q2 25
$-6.3M
$-804.0K
Q1 25
$-5.9M
$-3.2M
Q4 24
$-5.4M
$-3.1M
Q3 24
$-5.5M
$-12.7M
Q2 24
$-6.0M
$-303.0K
Q1 24
$-3.8M
$492.0K
Free Cash Flow
IMDX
IMDX
MSAI
MSAI
Q4 25
$-7.0M
$-2.6M
Q3 25
$-5.6M
$-2.1M
Q2 25
$-6.6M
$-1.3M
Q1 25
$-6.2M
$-3.6M
Q4 24
$-5.6M
$-4.1M
Q3 24
$-5.6M
$-13.2M
Q2 24
$-6.2M
$-844.0K
Q1 24
$-3.9M
$-79.0K
FCF Margin
IMDX
IMDX
MSAI
MSAI
Q4 25
-616.7%
-187.3%
Q3 25
-2135.4%
-136.1%
Q2 25
-1279.5%
-91.5%
Q1 25
-288.4%
-308.6%
Q4 24
-374.5%
-294.6%
Q3 24
-4884.3%
-823.2%
Q2 24
-5931.7%
-39.7%
Q1 24
-2189.8%
-3.5%
Capex Intensity
IMDX
IMDX
MSAI
MSAI
Q4 25
129.9%
26.2%
Q3 25
403.8%
21.5%
Q2 25
67.4%
34.8%
Q1 25
14.4%
37.2%
Q4 24
14.4%
76.2%
Q3 24
75.7%
30.5%
Q2 24
183.7%
25.5%
Q1 24
13.6%
25.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons